Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.66
+0.42 (5.10%)
At close: Apr 14, 2026, 4:00 PM EDT
8.66
0.00 (0.00%)
After-hours: Apr 14, 2026, 7:00 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$825,444
Profits / Employee
$58,444
Market Cap
447.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 900 | 0 | - |
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 334 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 147 |
| Ironwood Pharmaceuticals | 100 |
EBS News
- 5 days ago - Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program - GlobeNewsWire
- 7 days ago - Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness - GlobeNewsWire
- 12 days ago - Emergent BioSolutions Participates in Upcoming International Preparedness Conferences - GlobeNewsWire
- 20 days ago - Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures - GlobeNewsWire
- 4 weeks ago - Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look. - Barrons
- 6 weeks ago - Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness - GlobeNewsWire